Contact Us
Global Pharmaceutical Manufacturing Market Report 2025

Pharmaceutical Manufacturing Global Market Report 2025 - By Molecule Type (Biologics And Biosimilars, Conventional Drugs), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations), By Route Of Administration (Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations), By Therapy Area (Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases), By Sales Channel (Retail, Non-retail) - Market Size, Trends, And Global Forecast 2025-2034

Pharmaceutical Manufacturing Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : June 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Pharmaceutical Manufacturing Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Pharmaceutical Manufacturing Market?

Pharmaceutical manufacturing is the industrial process of developing, producing, and packaging medications and medical products at scale through chemical synthesis, biological processing, and formulation of active and inactive ingredients, carried out under stringent regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for human and veterinary use across global healthcare systems.

The main molecule types of pharmaceutical manufacturing include biologics and biosimilars, and conventional drugs. Tablets are solid, flat medications that contain a specified amount of active chemicals. Formulations include tablets, capsules, injectables, sprays, suspensions, powders, and others, and are administered through various routes, such as oral, topical, parenteral, inhalation, and others. It serves multiple therapy areas, including cardiovascular diseases (CVDs), pain, diabetes, cancer, respiratory diseases, and others, and is distributed through retail and non-retail sales channels.

Pharmaceutical Manufacturing Market Size and growth rate 2025 to 2029: Graph

What Is The Pharmaceutical Manufacturing Market Size 2025 And Growth Rate?

The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $519.78 billion in 2024 to $573.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing global disease burden, rising healthcare spending, growing generic drug demand, patent expirations of blockbuster drugs, and expansion of pharmaceutical production capacity.

What Is The Pharmaceutical Manufacturing Market Growth Forecast?

The pharmaceutical manufacturing market size is expected to see rapid growth in the next few years. It will grow to $846.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to personalized medicine growth, expanding elderly population, growing demand for biosimilars, government support for local manufacturing, and rising chronic disease prevalence. Major trends in the forecast period include advancements in continuous manufacturing, integration of artificial intelligence, adoption of smart manufacturing technologies, innovations in biologics production, and focus on research and development efficiency.

How Is The Pharmaceutical Manufacturing Market Segmented?

The pharmaceutical manufacturing market covered in this report is segmented –

1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations

4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

5) By Sales Channel: Retail, Non-retail

Subsegments:

1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, recombinant proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products

2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics

What Is Driving The Pharmaceutical Manufacturing Market? Rising Demand For Scalable Healthcare Solutions Due To Increasing Burden Of Chronic Illnesses

The increasing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical manufacturing market going forward. Chronic diseases are long-lasting health conditions that typically progress slowly and persist for a year or more, often requiring ongoing medical attention or limiting daily activities. The increasing prevalence of chronic diseases is due to rising life expectancy, sedentary lifestyles, and unhealthy dietary habits, leading to greater demand for long-term healthcare solutions and preventive wellness measures. Pharmaceutical manufacturing is useful for chronic diseases by ensuring a steady supply of essential medications, supporting innovation in drug development, and meeting the growing need for effective long-term treatment solutions. For instance, in September 2024, according to the National Health Service, a UK-based government department, 11% of adults aged 35 and older have advanced chronic kidney disease, with prevalence and severity rising with age. Nearly 48% of those aged 75 and above have some form of the disease, and 36% have more severe stages. Therefore, the increasing prevalence of chronic diseases is driving growth in the pharmaceutical manufacturing market.

Who Are The Major Players In The Global Pharmaceutical Manufacturing Market?

Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.

What Are The Key Trends Of The Global Pharmaceutical Manufacturing Market? Advancing Production Capabilities Through Automation And Technological Innovation

Major companies operating in the pharmaceutical manufacturing market are focusing on developing advanced solutions, such as fully automated RLT manufacturing facilities, to enhance production efficiency, ensure high-quality standards, and meet the growing demand for targeted cancer therapies. An automated RLT manufacturing facility is a state-of-the-art production site that uses advanced automation technologies to streamline and optimize the production of radioligand therapies, ensuring consistent, efficient, and scalable manufacturing. For instance, in January 2024, Novartis AG, a Switzerland-based pharmaceutical corporation, received US Food and Drug Administration (FDA) approval for Pluvicto production at a state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis, which will significantly increase production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This expansion is part of Novartis' broader strategy to meet the growing global demand for targeted cancer therapies and improve access for patients worldwide.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Manufacturing Market? Novo Holdings Acquires Catalent To Strengthen Pharmaceutical Production Capacity

In December 2024, Novo Holdings A/S, a Denmark-based asset management company, acquired Catalent for $16.5 billion. Through this acquisition, Novo Holdings aims to strengthen its position in the life sciences sector by leveraging Catalent's industry-leading expertise in drug development, manufacturing, and clinical supply management to accelerate growth, enhance patient outcomes, and create sustainable value within the pharmaceutical and biotechnology industries. Catalent Inc. is a US-based pharma company that provides pharmaceutical manufacturing services.

What Is The Regional Outlook For The Global Pharmaceutical Manufacturing Market?

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Manufacturing Market?

The pharmaceutical manufacturing market consists of revenues earned by entities by providing services such as contract manufacturing, formulation development, quality control and testing, and packaging and labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing market also includes sales of syrups, patch formulations, biologics, and antibiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmaceutical Manufacturing Industry?

The pharmaceutical manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical manufacturing market statistics, including the pharmaceutical manufacturing industry's global market size, regional shares, competitors with an pharmaceutical manufacturing market share, detailed pharmaceutical manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing industry. This pharmaceutical manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmaceutical Manufacturing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $573.95 billion
Revenue Forecast In 2034 $846.74 billion
Growth Rate CAGR of 10.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The pharmaceutical manufacturing market covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs
2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
5) By Sales Channel: Retail, Non-retail Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products
2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical Manufacturing Market Characteristics

    3. Pharmaceutical Manufacturing Market Trends And Strategies

    4. Pharmaceutical Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Pharmaceutical Manufacturing Growth Analysis And Strategic Analysis Framework

    5.1. Global Pharmaceutical Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Pharmaceutical Manufacturing Market Growth Rate Analysis

    5.4. Global Pharmaceutical Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Pharmaceutical Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Pharmaceutical Manufacturing Total Addressable Market (TAM)

    6. Pharmaceutical Manufacturing Market Segmentation

    6.1. Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Biologics And Biosimilars

    Conventional Drugs

    6.2. Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Capsules

    Injectable

    Sprays

    Suspensions

    Powders

    Other Formulations

    6.3. Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Topical

    Parenteral

    Inhalations

    Other Route Of Administrations

    6.4. Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Cardiovascular Diseases (CVDs)

    Pain

    Diabetes

    Cancer

    Respiratory Diseases

    Other Diseases

    6.5. Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Retail

    Non-retail

    6.6. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Monoclonal Antibodies

    Vaccines

    Recombinant Proteins

    Cell Therapies

    Gene Therapies

    Hormones

    Blood And Plasma Products

    6.7. Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Analgesics

    Antipyretics

    Antibiotics

    Antivirals

    Antifungals

    Antihypertensives

    Antidepressants

    Antidiabetics

    7. Pharmaceutical Manufacturing Market Regional And Country Analysis

    7.1. Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Pharmaceutical Manufacturing Market

    8.1. Asia-Pacific Pharmaceutical Manufacturing Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Pharmaceutical Manufacturing Market

    9.1. China Pharmaceutical Manufacturing Market Overview

    9.2. China Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Pharmaceutical Manufacturing Market

    10.1. India Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Pharmaceutical Manufacturing Market

    11.1. Japan Pharmaceutical Manufacturing Market Overview

    11.2. Japan Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Pharmaceutical Manufacturing Market

    12.1. Australia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Pharmaceutical Manufacturing Market

    13.1. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Pharmaceutical Manufacturing Market

    14.1. South Korea Pharmaceutical Manufacturing Market Overview

    14.2. South Korea Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Pharmaceutical Manufacturing Market

    15.1. Western Europe Pharmaceutical Manufacturing Market Overview

    15.2. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Pharmaceutical Manufacturing Market

    16.1. UK Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Pharmaceutical Manufacturing Market

    17.1. Germany Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Pharmaceutical Manufacturing Market

    18.1. France Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Pharmaceutical Manufacturing Market

    19.1. Italy Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Pharmaceutical Manufacturing Market

    20.1. Spain Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Pharmaceutical Manufacturing Market

    21.1. Eastern Europe Pharmaceutical Manufacturing Market Overview

    21.2. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Pharmaceutical Manufacturing Market

    22.1. Russia Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Pharmaceutical Manufacturing Market

    23.1. North America Pharmaceutical Manufacturing Market Overview

    23.2. North America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Pharmaceutical Manufacturing Market

    24.1. USA Pharmaceutical Manufacturing Market Overview

    24.2. USA Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Pharmaceutical Manufacturing Market

    25.1. Canada Pharmaceutical Manufacturing Market Overview

    25.2. Canada Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Pharmaceutical Manufacturing Market

    26.1. South America Pharmaceutical Manufacturing Market Overview

    26.2. South America Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Pharmaceutical Manufacturing Market

    27.1. Brazil Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Pharmaceutical Manufacturing Market

    28.1. Middle East Pharmaceutical Manufacturing Market Overview

    28.2. Middle East Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Pharmaceutical Manufacturing Market

    29.1. Africa Pharmaceutical Manufacturing Market Overview

    29.2. Africa Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Pharmaceutical Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Pharmaceutical Manufacturing Market Competitive Landscape

    30.2. Pharmaceutical Manufacturing Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Pharmaceutical Manufacturing Market Other Major And Innovative Companies

    31.1. Sanofi SA

    31.2. Bristol Myers Squibb Company

    31.3. Thermo Fisher Scientific Inc.

    31.4. AstraZeneca plc

    31.5. Abbott Laboratories

    31.6. Novartis AG

    31.7. GlaxoSmithKline plc

    31.8. Takeda Pharmaceuticals Inc.

    31.9. Eli Lilly and Company

    31.10. Gilead Sciences Inc.

    31.11. Novo Nordisk A/S

    31.12. Lonza Group AG

    31.13. Sun Pharmaceutical Industries Ltd.

    31.14. Dr. Reddy’s Laboratories

    31.15. Cipla Limited

    32. Global Pharmaceutical Manufacturing Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Pharmaceutical Manufacturing Market

    34. Recent Developments In The Pharmaceutical Manufacturing Market

    35. Pharmaceutical Manufacturing Market High Potential Countries, Segments and Strategies

    35.1 Pharmaceutical Manufacturing Market In 2029 - Countries Offering Most New Opportunities

    35.2 Pharmaceutical Manufacturing Market In 2029 - Segments Offering Most New Opportunities

    35.3 Pharmaceutical Manufacturing Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Services Inc. Financial Performance
  • Table 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 81: Merck & Co. Inc. Financial Performance
  • Table 82: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pharmaceutical Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pharmaceutical Manufacturing Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pharmaceutical Manufacturing Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pharmaceutical Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Pharmaceutical Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pharmaceutical Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pharmaceutical Manufacturing Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Pharmaceutical Manufacturing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Services Inc. Financial Performance
  • Figure 80: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 81: Merck & Co. Inc. Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Pharmaceutical Manufacturing market?

Pharmaceutical manufacturing is the industrial process of developing, producing, and packaging medications and medical products at scale through chemical synthesis, biological processing, and formulation of active and inactive ingredients, carried out under stringent regulatory and quality control standards to ensure the safety, efficacy, consistency, and compliance of drugs intended for human and veterinary use across global healthcare systems. For further insights on the Pharmaceutical Manufacturing market, request a sample here

How will the Pharmaceutical Manufacturing market drivers and restraints affect the market dynamics? What forces will shape the Pharmaceutical Manufacturing industry going forward?

The Pharmaceutical Manufacturing market major growth driver - Rising Demand For Scalable Healthcare Solutions Due To Increasing Burden Of Chronic Illnesses. For further insights on the Pharmaceutical Manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the Pharmaceutical Manufacturing market?

The Pharmaceutical Manufacturing market size has grown strongly in recent years. The pharmaceutical manufacturing market size has grown rapidly in recent years. It will grow from $519.78 billion in 2024 to $573.95 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing global disease burden, rising healthcare spending, growing generic drug demand, patent expirations of blockbuster drugs, and expansion of pharmaceutical production capacity. The pharmaceutical manufacturing market size is expected to see rapid growth in the next few years. It will grow to $846.74 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to personalized medicine growth, expanding elderly population, growing demand for biosimilars, government support for local manufacturing, and rising chronic disease prevalence. Major trends in the forecast period include advancements in continuous manufacturing, integration of artificial intelligence, adoption of smart manufacturing technologies, innovations in biologics production, and focus on research and development efficiency. For further insights on the Pharmaceutical Manufacturing market, request a sample here

How is the Pharmaceutical Manufacturing market segmented?

The pharmaceutical manufacturing market covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs
2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
5) By Sales Channel: Retail, Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products
2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics For further insights on the Pharmaceutical Manufacturing market,
request a sample here

Which region has the largest share of the Pharmaceutical Manufacturing market? What are the other regions covered in the report?

North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pharmaceutical Manufacturing market, request a sample here.

Who are the major players in the Pharmaceutical Manufacturing market?

Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited. . For further insights on the Pharmaceutical Manufacturing market, request a sample here.

What are the key trends in the Pharmaceutical Manufacturing market?

Major trends in the Pharmaceutical Manufacturing market include Advancing Production Capabilities Through Automation And Technological Innovation. For further insights on the Pharmaceutical Manufacturing market, request a sample here.

What are the major opportunities in the Pharmaceutical Manufacturing market? What are the strategies for the Pharmaceutical Manufacturing market?

For detailed insights on the major opportunities and strategies in the Pharmaceutical Manufacturing market, request a sample here.

How does the Pharmaceutical Manufacturing market relate to the overall economy and other similar markets?

For detailed insights on Pharmaceutical Manufacturing's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharmaceutical Manufacturing industry?

For detailed insights on the mergers and acquisitions in the Pharmaceutical Manufacturing industry, request a sample here.

What are the key dynamics influencing the Pharmaceutical Manufacturing market growth? SWOT analysis of the Pharmaceutical Manufacturing market.

For detailed insights on the key dynamics influencing the Pharmaceutical Manufacturing market growth and SWOT analysis of the Pharmaceutical Manufacturing industry, request a sample here.